Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

NCT02114229 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Malignant Rhabdoid Tumor
Atypical Teratoid Rhabdoid Tumor

Interventions

DRUG: alisertib
DRUG: methotrexate
DRUG: cisplatin
DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: topotecan
DRUG: vincristine
PROCEDURE: Surgical resection
RADIATION: Radiation therapy

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]